Search

everythinglearnresearchcommunity

for

Search:↓

Doctors need to be better prepared to assess and treat obesity in patients.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Human scalp hair follicles can be used to study how prolactin affects hair growth and cell death.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Testosterone therapy for transmasculine individuals is generally safe with medical supervision, improves mental health, and has mixed effects on physical health.

Skin problems in PCOS, like excess hair, acne, and hair loss, may not always indicate high male hormone levels and need careful diagnosis for proper treatment.

Finasteride's sexual side effects not caused by androgen deficiency or SRD5A inhibition.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

Manage women's cholesterol with diet, exercise, and careful treatment choices, especially during pregnancy, PCOS, and menopause.

Nonclassic adrenal hyperplasia is a genetic condition that can cause early puberty and fertility problems, treated with specific steroids.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Women with acromegaly often have irregular periods due to hormone imbalances and growth hormone effects.

New compounds may soon be tested to treat excessive hair growth in women.

Hormone treatments in transsexual individuals reduce hair growth and oil production in male-to-females and increase them in female-to-males.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Treating sleep apnea in young obese women with PCOS can improve heart health and insulin sensitivity.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

The sebaceous gland has more roles than just producing sebum and contributing to acne, and new research could lead to better skin disease treatments.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

A new mutation in the human glucocorticoid receptor reduces its function and causes resistance to glucocorticoids.

Spironolactone can cause side effects like irregular bleeding, but lower doses may reduce these effects and still improve hirsutism.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

The skin's ability to produce hormones is linked to various skin conditions, and better understanding this process could lead to new treatments.